Coronary revascularisation is more often used in patients at small risk and with little to gain than in patients at high risk and much to gain. This is against current guide-lines and is wasteful. The problem if aggravated by socioeconomic bias. A redesigned reimbursement system, based on measured improved quality of life and survival, would encourage a more efficient use of resources.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.3109/14017431.2010.497558 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!